The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Wright
Wendy L
WL
Wright & Associates Family Healthcare and Partners in Healthcare Education, LLC, Amherst, NH, USA.
D000499:Allylamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D000069472:Colesevelam Hydrochloride; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D018450:Disease Progression; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000600:supply & distribution / Q000627:therapeutic use; D008019:Life Style; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000499:Allylamine; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000069472:Colesevelam Hydrochloride; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents